Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis

SIMPLE SUMMARY: Immunotherapy has revolutionized the therapeutic options for patients living with non-small-cell lung cancer (NSCLC). Despite the unprecedented results achieved through immunotherapy, a low body mass index, which is referred to as cachexia, and the bacterial composition of the gut mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakozaki, Taiki, Nolin-Lapalme, Alexis, Kogawa, Masato, Okuma, Yusuke, Nakamura, Shohei, Moreau-Amaru, Danielle, Tamura, Taichi, Hosomi, Yukio, Takeyama, Haruko, Richard, Corentin, Hosokawa, Masahito, Routy, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658074/
https://www.ncbi.nlm.nih.gov/pubmed/36358821
http://dx.doi.org/10.3390/cancers14215405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658074/
https://www.ncbi.nlm.nih.gov/pubmed/36358821
http://dx.doi.org/10.3390/cancers14215405

Ejemplares similares